Avenue Therapeutics Inc. buy Aegis
Start price
03.04.23
/
50%
€1.09
Target price
03.04.24
€29.35
Performance (%)
-87.88%
End price
04.04.24
€0.13
Summary
This prediction ended on 04.04.24 with a price of €0.13. The BUY prediction by Aegis for Avenue Therapeutics Inc. performed very badly with a performance of -87.88%. Aegis has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Avenue Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % | 45,10 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % | 76,36 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % | 49,59 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % | 57,07 % |
Comments by Aegis for this prediction
In the thread Avenue Therapeutics Inc. diskutieren
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Aegis. They set a "buy" rating and a $32.00 price target on the stock.
Ratings data for ATXI provided by MarketBeat
In the thread Trading Avenue Therapeutics Inc.
Die von Aegis gewählte maximale Laufzeit wurde überschritten